Lead Product(s) : Undisclosed
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Discovery
Sponsor : CSIR-CDRI
Deal Size : Undisclosed
Deal Type : Agreement
Zydus and CSIR-CDRI Lucknow to Develop Drug for CKD Induced Osteoporosis
Details : The collaboration inked between the parties aims to develop oral medication through the discovery of small molecule inhibitors of Sclerostin.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
September 27, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Discovery
Sponsor : CSIR-CDRI
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?